APA

Lübben G., Hübner R., . (20020214). [Drug interactions as exemplified by thiazolidinediones (glitazones). Commentary on the publication of Ulrich Klotz and Dietmar Sailer, "Drug interactions--their impact on safe drug therapy in the example of the new thiazolidinedione group (glitazone)"Arzneimittelforschung. 2001 Feb;51(2):112-7]. : Arzneimittel-Forschung.

Chicago

Lübben G, Hübner R, . 20020214. [Drug interactions as exemplified by thiazolidinediones (glitazones). Commentary on the publication of Ulrich Klotz and Dietmar Sailer, "Drug interactions--their impact on safe drug therapy in the example of the new thiazolidinedione group (glitazone)"Arzneimittelforschung. 2001 Feb;51(2):112-7]. : Arzneimittel-Forschung.

Harvard

Lübben G., Hübner R., . (20020214). [Drug interactions as exemplified by thiazolidinediones (glitazones). Commentary on the publication of Ulrich Klotz and Dietmar Sailer, "Drug interactions--their impact on safe drug therapy in the example of the new thiazolidinedione group (glitazone)"Arzneimittelforschung. 2001 Feb;51(2):112-7]. : Arzneimittel-Forschung.

MLA

Lübben G, Hübner R, . [Drug interactions as exemplified by thiazolidinediones (glitazones). Commentary on the publication of Ulrich Klotz and Dietmar Sailer, "Drug interactions--their impact on safe drug therapy in the example of the new thiazolidinedione group (glitazone)"Arzneimittelforschung. 2001 Feb;51(2):112-7]. : Arzneimittel-Forschung. 20020214.